Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

33 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

NCT01991561

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: INC Research Toronto, Ontario, Canada

MUHC Vaccine Study Center Pierrefonds, Quebec, Canada

View Trial Details

Completed

Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

NCT02768805

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Broward Research Group (BRG) Hollywood, Florida, United States

Miami Research Associates (MRA) South Miami, Florida, United States

Regional Clinical Research (RCR) Endwell, New York, United States

Topstone Research Toronto, Ontario, Canada

View Trial Details

Completed

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

NCT01991587

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Miami Research Associates Miami, Florida, United States

View Trial Details

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

NCT02233816

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Broward Research Group Hollywood, Florida, United States

Miami Research Associates Miami, Florida, United States

View Trial Details

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population

NCT02236052

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: MUHC-Vaccine Study Centre Pierrefonds, Quebec, Canada

Centre de recherche-CHU de Québec Québec, Canada

inVentiv Health Clinique Québec, Canada

View Trial Details

Completed

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

NCT02831751

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Paradigm Research - Redding Redding, California, United States

Broward Research Group (BRG) Hollywood, Florida, United States

Miami Research Associates (MRA) South Miami, Florida, United States

Meridian Clinical Research - Savannah Savannah, Georgia, United States

View all 15 locations

View Trial Details

Completed

Centralized Reminder Recall - Flu RCT2

NCT03294473

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +8 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

NCT03392207

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +6 more
Locations: Crie - Unifesp São Paulo, Brazil

Avenida Vital Brasil 1500 São Paulo, Brazil

View Trial Details

Completed

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

NCT02630082

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.

NCT02022163

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Canadian Science Centre for Human and Animal Health Winnipeg, Manitoba, Canada

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions